SCA Pharma March 2022 Report
Snapshot
Total Users
4,302 New Users
Total Pageviews
8,898 Unique Pageviews
Sessions
1.45 Pages/Session
Avg. Time on Page
%
Bounce Rate
Compare to February 2022:
Total Users
4,092 New Users
Total Pageviews
8,571 Unique Pageviews
Sessions
1.49 Pages/Session
Avg. Time on Page
%
Bounce Rate
Key Insights
| Page | Pageviews | Unique Pageviews | Avg. Time on Page | Entrances | Bounce Rate | % Exit | |
| 1 | / | 5,505 | 4,857 | 0:02:26 | 4,792 | 37.8% | 74.0% |
| 2 | /careers/ | 1,208 | 957 | 0:04:18 | 754 | 48.8% | 74.4% |
| 3 | /products/ | 880 | 725 | 0:01:51 | 268 | 52.9% | 59.7% |
| 4 | /contact-page/ | 424 | 366 | 0:02:28 | 218 | 59.2% | 68.4% |
| 5 | /why-sca/ | 302 | 263 | 0:01:02 | 90 | 67.0% | 43.1% |
| 6 | /why-outsource-503b/ | 197 | 182 | 0:01:23 | 41 | 69.1% | 43.7% |
| 7 | /why-sca/our-leadership/ | 127 | 117 | 0:01:49 | 18 | 66.7% | 52.0% |
| 8 | /why-sca/state-of-the-art-facilities/ | 119 | 102 | 0:02:20 | 59 | 62.7% | 58.8% |
| 9 | /news-and-events/ | 107 | 96 | 0:00:35 | 18 | 44.4% | 47.7% |
| 10 | /quality/ | 103 | 94 | 0:02:49 | 20 | 31.8% | 49.5% |
| Region | Users | New Users | Sessions | Bounce Rate | Pages / Session | Avg. Session Duration | |
| 1 | Connecticut | 856 | 774 | 1,137 | 63.4% | 1.46 | 0:01:20 |
| 2 | Arkansas | 338 | 313 | 480 | 43.8% | 1.55 | 0:01:36 |
| 3 | Virginia | 292 | 282 | 339 | 71.7% | 1.17 | 0:00:13 |
| 4 | New York | 289 | 234 | 456 | 34.4% | 1.42 | 0:01:00 |
| 5 | California | 282 | 231 | 461 | 25.0% | 1.47 | 0:01:05 |
| 6 | Texas | 273 | 231 | 405 | 45.2% | 1.44 | 0:00:58 |
| 7 | Massachusetts | 228 | 199 | 301 | 39.5% | 1.65 | 0:01:14 |
| 8 | Florida | 169 | 154 | 251 | 50.2% | 1.48 | 0:00:47 |
| 9 | Illinois | 134 | 115 | 280 | 23.9% | 1.55 | 0:02:01 |
| 10 | Pennsylvania | 108 | 71 | 275 | 15.6% | 1.29 | 0:00:48 |
| Default Channel Grouping | Users | New Users | Sessions | Bounce Rate | Pages / Session | Avg. Session Duration | |
| 1 | Direct | 2,394 | 2,194 | 3,244 | 55.5% | 1.19 | 0:00:41 |
| 2 | Organic Search | 1,646 | 1,354 | 2,244 | 34.9% | 1.73 | 0:01:34 |
| 3 | Paid Search | 797 | 643 | 1,144 | 40.0% | 1.47 | 0:00:44 |
| 4 | Referral | 186 | 61 | 352 | 29.8% | 1.89 | 0:01:52 |
| 5 | Social | 53 | 50 | 61 | 60.7% | 1.41 | 0:00:37 |
March 2022 Portal Stats
Total Users
228 New Users
Total Pageviews
2,786 Unique Pageviews
Sessions
5.21 Pages/Session
Avg. Time on Page
%
Bounce Rate
The portal link on the regular website was clicked 2,136 times in the month of March.
The top day for portal homepage views was Wednesday, March 16th with 127 views.
Top pages viewed:
| Page | Pageviews | Unique Pageviews | Avg. Time on Page | Entrances | Bounce Rate | % Exit | |
| 1 | / | 1,456 | 1,170 | 0:00:42 | 578 | 18.2% | 14.2% |
| 2 | /orders-in-process | 987 | 370 | 0:01:27 | 0 | 0.0% | 20.4% |
| 3 | /order-history | 297 | 213 | 0:02:15 | 2 | 50.0% | 28.6% |
| 4 | /login?error= | 200 | 115 | 0:00:49 | 16 | 18.8% | 7.5% |
| 5 | /buy-now | 176 | 122 | 0:02:34 | 0 | 0.0% | 18.8% |
| 6 | /login | 166 | 159 | 0:00:30 | 138 | 18.8% | 16.3% |
| 7 | /orders/order | 160 | 116 | 0:01:03 | 0 | 0.0% | 18.8% |
| 8 | /login?logout= | 142 | 117 | 0:01:24 | 37 | 40.5% | 71.1% |
| 9 | /certificates | 93 | 32 | 0:00:52 | 0 | 0.0% | 17.2% |
| 10 | /product-catalog | 82 | 61 | 0:02:36 | 0 | 0.0% | 36.6% |
Note – these pageviews are the amount of times a page was viewed. For example, a “view” for the /buy-now page does not necessarily mean someone completed a purchase when they viewed that page, and a “view” for the /newaccountform page does not necessarily mean someone completed the form when they viewed that page. These numbers would have to be compared to the numbers of orders purchased and the number of new account creations made on the backend of the portal website.
March 2022 Emails
| Date Sent | Campaign Name | Sends | Opens | Open Rate | Clicks | Click Rate | Bounces | Bounce Rate | Unsubs | |
| 1 | 3/4/22 | Employee Appreciation Day 2022 | 683 | 236 | 35.3% | 91 | 13.6% | 14 | 2.0% | 0 |
| 2 | 3/7/22 | Norepinephrine Extended Dating 2022 | 9,589 | 940 | 13.5% | 70 | 1.0% | 2610 | 27.2% | 3 |
| 3 | 3/21/22 | Buy and Ship Now 3.22 | 9,585 | 1,176 | 16.9% | 247 | 3.5% | 2626 | 27.4% | 17 |
| 4 | 3/23/22 | Welcome Marcus Najem | 684 | 218 | 32.6% | 0 | 0.0% | 16 | 2.3% | 0 |
| 5 | 3/31/22 | Vancomycin 1g | 9,567 | 809 | 11.4% | 0 | 0.0% | 2441 | 25.5% | 5 |
| 6 | 3/31/22 | Organizational Announcement | 685 | 208 | 31.1% | 0 | 0.0% | 16 | 2.3% | 0 |
March 2022 Social Platform Data
LI Pageviews
548 Desktop LI Pageviews
604 Mobile LI Pageviews
Total Followers
84 New Followers in March
Top 5 Visitor Locations
- Greater NYC Area
- Greater Boston Area
- Hartford, CT Area
- Greater Chicago Area
- Little Rock, Arkansas Area
Total Posts
| Update link | Posted date | Impressions | Clicks | CTR | Likes | Comments | Shares | Engage. rate | |
| 1 | linkedin.com | 3/4/22 | 2,626 | 119 | 4.5% | 65 | 5 | 13 | 7.7% |
| 2 | linkedin.com | 3/7/22 | 930 | 17 | 1.8% | 20 | 0 | 9 | 4.9% |
| 3 | linkedin.com | 3/8/22 | 1,072 | 71 | 6.6% | 27 | 0 | 7 | 9.8% |
| 4 | linkedin.com | 3/17/22 | 743 | 32 | 4.3% | 20 | 0 | 16 | 9.2% |
| 5 | linkedin.com | 3/28/22 | 756 | 28 | 3.7% | 31 | 0 | 9 | 9.0% |
Profile Visits
Total Followers
Tweet Impressions
March 2022 Google Ads Data
| Ad type | Final URL | Headlines and Descriptions | Clicks | Impr. | CTR | Avg. CPC | Cost | ||||
| 1 | Responsive search ad | https://scapharma.com/ | SCA Pharma | 503B Outsourcing Facility | Pharmaceutical Quality System | State-of-the-art Facilities | 948 | 12,254 | 7.74% | $0.34 | $320.31 |
| Outsourcing 503B | Leading 503B Organization | Outstanding 503B Quality | Outsource Sterile Compounding | ||||||||
| Descriptions: 1. SCA Pharma features state-of-the-art production facilities designed with quality in mind. 2. A 503B outsourcing facility providing the highest quality sterile compounded products. 3. SCA Pharma offers an extensive product portfolio and outstanding quality. 4. Contact SCA Pharma to discuss your 503B outsourcing needs. | |||||||||||
| 2 | Expanded text ad | https://scapharma.com/ | FDA 503B Outsourcing Facility | SCA Pharma | Providing Critical Medicines | — | 16 | 753 | 2.12% | $0.66 | $ 10.58 |
| Descriptions: 1. SCA Pharma is a leader in defining Quality for the 503B Outsourcing market. 2. The result is that you can depend on us to deliver safe and effective medicines. | |||||||||||
| 3 | Expanded text ad | https://scapharma.com/ | SCA Pharma | 503B Outsourcing Facility | Pharmaceutical Quality System | — | 35 | 1,133 | 3.09% | $0.46 | $ 15.97 |
| Descriptions: 1. Providing critical medicines patients can depend on and clinical practitioners can trust. 2. You can count on SCA Pharma products to deliver the quality and consistency you require. | |||||||||||
| 4 | Expanded text ad | https://scapharma.com/ | SCA Pharma | Leading 503B Organization | 503B Outsourcing Facility | — | 7 | 584 | 1.2% | $0.39 | $ 2.72 |
| Descriptions: 1. Exceptional people. Rigorous product testing. State of the art facilities. 2. SCA Pharma provides the highest quality sterile admixtures and pre-filled syringes. | |||||||||||
| 5 | Expanded dynamic search ad | [Dynamically generated display URL] | [Dynamically generated headline] | 23 | 177 | 12.99% | $0.35 | $8.08 | |||
| Description: A 503B outsourcing facility providing the highest quality sterile compounded products. SCA Pharma offers an extensive product portfolio and outstanding quality. | |||||||||||
| Totals: | 1,029 | 14,901 | 6.91% | $0.35 | $357.66 | ||||||